冷圈套分块EMR切除≥20mm无蒂结肠息肉的安全性与有效性
该回顾性研究纳入5家澳大利亚学术医院2年内186例患者共204枚≥20mm无蒂结肠息肉,评估冷圈套分块EMR(CSP-EMR)的安全性和有效性。CSP-EMR技术可行、有效且安全,不良事件率和息肉复发率均较低。
要点
- CSP-EMR切除≥20mm无蒂结肠息肉首次监视结肠镜息肉残留/复发率为5.5%。
- 第二次监视结肠镜迟发残留/复发率为3.5%,均发生在首次监视正常者之后。
- 术中出血4例(2.2%),术后自限性临床显著出血7例(3.8%),无其他不良事件。
核心结论
- CSP-EMR切除≥20mm无蒂结肠息肉技术可行、有效且安全,不良事件率和息肉复发率均较低。
研究设计与样本
- 共204枚≥20mm息肉,来自186例患者(男性33.8%,中位年龄68岁)。
主要发现
- 首次监视结肠镜(SC1)覆盖164枚息肉(80.4%),中位间隔150天,残留或复发9例(5.5%;95%CI 3%-11%)。
关键数值与推荐
- 有效性定义为首次和第二次监视结肠镜期间无残留或复发息肉组织。
- 息肉大小≥20mm,无蒂结肠息肉,非恶性。
临床怎么用
- CSP-EMR可作为≥20mm无蒂结肠息肉的一种治疗选择,避免电灼相关严重不良事件。
- 术后需按计划进行监视结肠镜以监测残留或复发。
局限性
- 回顾性研究设计。
- 需随机或大型前瞻性试验确认CSP-EMR相对于传统EMR的非劣效性和安全性优势,并进一步确定最适合CSP-EMR的息肉形态。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Conventional EMR using a hot snare is the standard of care for resection of large (≥20 mm) nonmalignant sessile colonic polyps. Serious adverse events are predominantly because of electrocautery. This could potentially be avoided by cold snare piecemeal EMR (CSP-EMR). This study aimed to evaluate the safety and efficacy of CSP-EMR of sessile colonic polyps sized ≥20 mm. METHODS: All cases of CSP-EMR at 5 Australian academic hospitals for sessile polyps ≥20 mm over a 2-year period, from January 2016 to December 2017, were identified retrospectively. Efficacy was defined as the absence of residual or recurrent polyp tissue during the first surveillance colonoscopy (SC1) and second surveillance colonoscopy (SC2). Clinically significant intraprocedural or delayed adverse events and surveillance colonoscopy findings were assessed by reviewing medical records. RESULTS: CSP-EMR was performed on 204 polyps sized ≥20 mm in 186 patients (men, 33.8%; median age, 68 years). SC1 for 164 polyps (80.4%) at a median interval of 150 days showed residual or recurrent polyp in 9 cases (5.5%; 95% confidence interval, 3%-11%). SC2 for 113 polyps (72.9%) at a median interval of 18 months showed late residual or recurrent polyp in 4 cases (3.5%; 95% confidence interval, .9%-8.5%) after a normal SC1. Intraprocedural bleeding was successfully treated in 4 patients (2.2%), whereas 7 patients (3.8%) experienced self-limited clinically significant post-EMR bleeding and 1 patient (.5%) required overnight observation for nonspecific abdominal pain that resolved spontaneously. None experienced other adverse events. CONCLUSIONS: CSP-EMR of sessile colonic polyps ≥20 mm is technically feasible, effective, and safe. The adverse event rate and polyp recurrence rate were low. Randomized or large prospective trials are required to confirm the noninferiority and improved safety of CSP-EMR compared with conventional EMR and to further determine the polyp morphologies that are best suited for CSP-EMR.
引用
- Mangira D, Cameron K, Simons K, et al. Cold snare piecemeal EMR of large sessile colonic polyps ≥20 mm (with video). Gastrointest Endosc. 2020. PMID: 31954132. doi:10.1016/j.gie.2019.12.051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。